Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
64.8M
-
Shares change
-
+4.43M
-
Total reported value, excl. options
-
$401M
-
Value change
-
+$19.7M
-
Put/Call ratio
-
0.07
-
Number of buys
-
75
-
Number of sells
-
-59
-
Price
-
$6.20
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q2 2024
169 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.8M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11.6M shares), RTW INVESTMENTS, LP (5.85M shares), FMR LLC (5.33M shares), BlackRock Inc. (4.8M shares), VANGUARD GROUP INC (3.07M shares), COWEN AND COMPANY, LLC (2.96M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.54M shares), TRV GP IV, LLC (2.34M shares), CITADEL ADVISORS LLC (1.78M shares), and DIMENSIONAL FUND ADVISORS LP (1.48M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.